BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 6185897)

  • 21. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental proteins as tumor markers.
    Braunstein GD
    Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 30. An immunohistochemical study of intracranial germ cell tumours.
    Yamagami T; Handa H; Yamashita J; Okumura T; Paine J; Haebara H; Furukawa F
    Acta Neurochir (Wien); 1987; 86(1-2):33-41. PubMed ID: 2441574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
    Samaan NA; Smith JP; Rutledge FN; Schultz PN
    Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
    Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
    J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
    Vugrin D; Friedman A; Whitmore WF
    Cancer; 1984 Mar; 53(6):1440-5. PubMed ID: 6198071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers in testicular tumors].
    Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
    Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).
    Talerman A; Haije WG; Baggerman L
    Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):999-1011. PubMed ID: 2430437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.